
<table style="text-align:center"><caption><strong>Poisson Models of Market Authorizations for New Orphan Drugs (Not adjusted for Error Structure)</strong></caption>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"></td><td colspan="5"><em>Dependent variable:</em></td></tr>
<tr><td></td><td colspan="5" style="border-bottom: 1px solid black"></td></tr>
<tr><td style="text-align:left"></td><td colspan="5">Annual Number of Market Authorizations for New Orphan Drugs</td></tr>
<tr><td style="text-align:left"></td><td>Model 1</td><td>Model 2</td><td>Model 3</td><td>Model 4</td><td>Model 5</td></tr>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">US (β<sup>̂</sup><sub>1</sub>)</td><td>0.905<sup>***</sup></td><td>0.859<sup>***</sup></td><td>0.682<sup>***</sup></td><td>0.933<sup>***</sup></td><td>0.984</td></tr>
<tr><td style="text-align:left"></td><td>(0.086)</td><td>(0.178)</td><td>(0.196)</td><td>(0.349)</td><td>(0.682)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004 (β<sup>̂</sup><sub>2</sub>)</td><td>0.076<sup>***</sup></td><td>0.072<sup>***</sup></td><td>0.061<sup>***</sup></td><td></td><td>0.046</td></tr>
<tr><td style="text-align:left"></td><td>(0.008)</td><td>(0.018)</td><td>(0.014)</td><td></td><td>(0.055)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD) (β<sup>̂</sup><sub>3</sub>)</td><td></td><td>0.002</td><td></td><td>0.047<sup>***</sup></td><td>0.013</td></tr>
<tr><td style="text-align:left"></td><td></td><td>(0.006)</td><td></td><td>(0.011)</td><td>(0.043)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual GDP Growth Rate Per Capita (β<sup>̂</sup><sub>4</sub>)</td><td></td><td>0.002</td><td>0.001</td><td>-0.002</td><td>0.002</td></tr>
<tr><td style="text-align:left"></td><td></td><td>(0.008)</td><td>(0.008)</td><td>(0.008)</td><td>(0.008)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004:US (β<sup>̂</sup><sub>5</sub>)</td><td></td><td></td><td>0.021</td><td></td><td>0.054</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td>(0.017)</td><td></td><td>(0.061)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD):US (β<sup>̂</sup><sub>6</sub>)</td><td></td><td></td><td></td><td>-0.023<sup>*</sup></td><td>-0.018</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td>(0.012)</td><td>(0.044)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Intercept (β<sup>̂</sup><sub>0</sub>)</td><td>1.636<sup>***</sup></td><td>1.628<sup>***</sup></td><td>1.788<sup>***</sup></td><td>1.154<sup>***</sup></td><td>1.602<sup>**</sup></td></tr>
<tr><td style="text-align:left"></td><td>(0.110)</td><td>(0.111)</td><td>(0.166)</td><td>(0.314)</td><td>(0.651)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">AIC</td><td>216</td><td>220</td><td>218</td><td>233</td><td>222</td></tr>
<tr><td style="text-align:left">RMSE</td><td>4.72</td><td>4.76</td><td>4.67</td><td>5.63</td><td>4.62</td></tr>
<tr><td style="text-align:left">Log Likelihood</td><td>-104.85</td><td>-104.77</td><td>-104.04</td><td>-111.38</td><td>-103.76</td></tr>
<tr><td colspan="6" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"><em>Note:</em></td><td colspan="5" style="text-align:right"><sup>*</sup>p<0.1; <sup>**</sup>p<0.05; <sup>***</sup>p<0.01</td></tr>
</table>
